Načítá se...
SRC Promotes Tamoxifen Resistance in Breast Cancer via Up-Regulating SIRT1
BACKGROUND: Endocrine therapy plays a key role in estrogen receptor-positive breast cancer patients; but, tamoxifen resistance could be a real difficulty for these patients. Several attempts have been made to explore the mechanism and new therapies for these patients. We intend to clarify the expr...
Uloženo v:
| Vydáno v: | Onco Targets Ther |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7259490/ https://ncbi.nlm.nih.gov/pubmed/32547094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S245749 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|